Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 41 | 2024 | 1913 | 4.440 |
Why?
|
Sigma Factor | 12 | 2016 | 176 | 2.950 |
Why?
|
Bacterial Proteins | 25 | 2024 | 3846 | 2.700 |
Why?
|
Gene Expression Regulation, Bacterial | 19 | 2024 | 1133 | 2.020 |
Why?
|
Mycobacterium smegmatis | 6 | 2016 | 126 | 1.190 |
Why?
|
Bacterial Toxins | 6 | 2024 | 931 | 1.040 |
Why?
|
Didanosine | 15 | 2005 | 151 | 0.910 |
Why?
|
RNA, Bacterial | 8 | 2021 | 393 | 0.890 |
Why?
|
Regulon | 2 | 2016 | 71 | 0.820 |
Why?
|
Genes, Bacterial | 7 | 2016 | 1073 | 0.770 |
Why?
|
Lymphadenitis | 4 | 2001 | 99 | 0.640 |
Why?
|
Zidovudine | 11 | 2005 | 624 | 0.620 |
Why?
|
Endoribonucleases | 5 | 2019 | 228 | 0.580 |
Why?
|
Genes, Essential | 2 | 2016 | 185 | 0.560 |
Why?
|
Mycobacterium | 5 | 2001 | 251 | 0.520 |
Why?
|
Peptidoglycan | 3 | 2017 | 249 | 0.520 |
Why?
|
Antitubercular Agents | 2 | 2020 | 1374 | 0.470 |
Why?
|
Mycobacterium avium-intracellulare Infection | 4 | 2000 | 76 | 0.470 |
Why?
|
Cell Division | 3 | 2011 | 4466 | 0.440 |
Why?
|
Promoter Regions, Genetic | 9 | 2024 | 5789 | 0.430 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 371 | 0.420 |
Why?
|
Transcription, Genetic | 8 | 2016 | 7595 | 0.410 |
Why?
|
Operon | 3 | 2024 | 372 | 0.400 |
Why?
|
Mycobacterium leprae | 3 | 2007 | 95 | 0.380 |
Why?
|
Virulence Factors | 2 | 2014 | 513 | 0.380 |
Why?
|
Zinc | 1 | 2015 | 690 | 0.370 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2000 | 662 | 0.360 |
Why?
|
Mycobacterium Infections | 2 | 2001 | 122 | 0.340 |
Why?
|
Antitoxins | 2 | 2024 | 77 | 0.330 |
Why?
|
Phosphorylation | 8 | 2024 | 8320 | 0.330 |
Why?
|
Stress, Physiological | 2 | 2016 | 1403 | 0.330 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2005 | 832 | 0.310 |
Why?
|
Oxidative Stress | 5 | 2021 | 3110 | 0.300 |
Why?
|
Pseudogenes | 1 | 2007 | 104 | 0.290 |
Why?
|
Adaptation, Physiological | 1 | 2014 | 1301 | 0.290 |
Why?
|
Mycobacterium avium Complex | 2 | 2000 | 59 | 0.290 |
Why?
|
RNA, Ribosomal, 23S | 3 | 2015 | 54 | 0.280 |
Why?
|
Cell Wall | 2 | 2021 | 425 | 0.280 |
Why?
|
Zalcitabine | 5 | 1993 | 43 | 0.270 |
Why?
|
Macrolides | 2 | 2005 | 205 | 0.270 |
Why?
|
Peptide Synthases | 1 | 2006 | 80 | 0.270 |
Why?
|
Tuberculosis | 4 | 2022 | 2016 | 0.270 |
Why?
|
Virulence | 5 | 2019 | 1302 | 0.260 |
Why?
|
Molecular Sequence Data | 14 | 2012 | 17644 | 0.260 |
Why?
|
RNA, Transfer | 3 | 2019 | 292 | 0.250 |
Why?
|
Student Health Services | 1 | 2004 | 40 | 0.240 |
Why?
|
Protein Binding | 6 | 2024 | 9352 | 0.240 |
Why?
|
HIV-1 | 10 | 2005 | 6860 | 0.230 |
Why?
|
Primary Prevention | 2 | 2004 | 1186 | 0.230 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 1995 | 2199 | 0.220 |
Why?
|
Substrate Specificity | 5 | 2012 | 1791 | 0.220 |
Why?
|
Base Sequence | 12 | 2016 | 12450 | 0.210 |
Why?
|
Binding Sites | 5 | 2016 | 6055 | 0.210 |
Why?
|
Peptides | 2 | 2011 | 4345 | 0.200 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2001 | 28 | 0.190 |
Why?
|
Ribosomes | 3 | 2021 | 501 | 0.190 |
Why?
|
Cord Factors | 1 | 2020 | 6 | 0.180 |
Why?
|
Transformation, Bacterial | 3 | 1998 | 76 | 0.180 |
Why?
|
Water Microbiology | 1 | 2000 | 113 | 0.170 |
Why?
|
Tuberculosis, Meningeal | 1 | 1999 | 47 | 0.160 |
Why?
|
HIV Infections | 21 | 2005 | 17347 | 0.160 |
Why?
|
Copper | 1 | 2021 | 369 | 0.160 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 1999 | 97 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 238 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 1999 | 255 | 0.150 |
Why?
|
Gene Deletion | 3 | 2014 | 2667 | 0.150 |
Why?
|
Heat-Shock Response | 1 | 1999 | 179 | 0.150 |
Why?
|
Escherichia coli | 9 | 2015 | 4218 | 0.150 |
Why?
|
Communicable Disease Control | 1 | 2004 | 846 | 0.150 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2008 | 2871 | 0.150 |
Why?
|
Signal Transduction | 4 | 2018 | 23441 | 0.150 |
Why?
|
DNA, Bacterial | 6 | 2012 | 1479 | 0.140 |
Why?
|
Amino Acid Sequence | 9 | 2012 | 13449 | 0.140 |
Why?
|
Mycobacterium bovis | 4 | 2020 | 147 | 0.140 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2010 | 2748 | 0.140 |
Why?
|
Genetic Complementation Test | 2 | 2008 | 555 | 0.140 |
Why?
|
BCG Vaccine | 1 | 2020 | 369 | 0.140 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 3447 | 0.130 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6215 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1974 | 0.130 |
Why?
|
Recombination, Genetic | 2 | 1998 | 1525 | 0.130 |
Why?
|
Ribosomal Protein S6 | 1 | 2015 | 71 | 0.120 |
Why?
|
Drug Therapy, Combination | 11 | 2012 | 6309 | 0.120 |
Why?
|
Subtilisins | 1 | 2014 | 81 | 0.120 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 227 | 0.120 |
Why?
|
Disulfides | 2 | 2008 | 465 | 0.110 |
Why?
|
Clarithromycin | 1 | 1994 | 86 | 0.110 |
Why?
|
Bacterial Load | 1 | 2014 | 151 | 0.110 |
Why?
|
Ribosome Subunits, Small, Bacterial | 1 | 2013 | 4 | 0.110 |
Why?
|
Ribosome Subunits, Large, Bacterial | 1 | 2013 | 5 | 0.110 |
Why?
|
Membrane Glycoproteins | 1 | 2024 | 3702 | 0.110 |
Why?
|
RNA-Binding Proteins | 2 | 2013 | 1897 | 0.110 |
Why?
|
Infant | 23 | 2012 | 36205 | 0.110 |
Why?
|
HIV Antibodies | 3 | 1995 | 1303 | 0.110 |
Why?
|
Protein Biosynthesis | 3 | 2021 | 2114 | 0.100 |
Why?
|
Larva Migrans | 1 | 2012 | 7 | 0.100 |
Why?
|
Central Nervous System Helminthiasis | 1 | 2012 | 5 | 0.100 |
Why?
|
Casein Kinase II | 1 | 2012 | 122 | 0.100 |
Why?
|
Ascaridoidea | 1 | 2012 | 8 | 0.100 |
Why?
|
Culture Media | 1 | 2014 | 896 | 0.100 |
Why?
|
Bacteremia | 1 | 1998 | 978 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 1989 | 0.100 |
Why?
|
Blotting, Southern | 3 | 1999 | 780 | 0.100 |
Why?
|
Amino Acid Motifs | 2 | 2012 | 931 | 0.090 |
Why?
|
Carbon | 1 | 2014 | 665 | 0.090 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 484 | 0.090 |
Why?
|
Carrier Proteins | 1 | 2003 | 4936 | 0.090 |
Why?
|
Child, Preschool | 25 | 2001 | 42254 | 0.090 |
Why?
|
Cytoplasm | 1 | 2014 | 1511 | 0.090 |
Why?
|
Genetic Vectors | 3 | 2016 | 3395 | 0.080 |
Why?
|
Polymerase Chain Reaction | 6 | 1999 | 6086 | 0.080 |
Why?
|
Phenotype | 4 | 2016 | 16606 | 0.080 |
Why?
|
Proteome | 1 | 2019 | 1862 | 0.080 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4525 | 0.080 |
Why?
|
Peptide Library | 2 | 2012 | 347 | 0.080 |
Why?
|
Hot Temperature | 2 | 2007 | 1440 | 0.080 |
Why?
|
alpha-Crystallins | 1 | 2007 | 4 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1995 | 1351 | 0.070 |
Why?
|
Immunoblotting | 1 | 2011 | 1647 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1320 | 0.070 |
Why?
|
Sequence Analysis, DNA | 3 | 2008 | 4741 | 0.070 |
Why?
|
HIV Core Protein p24 | 5 | 1995 | 245 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9606 | 0.070 |
Why?
|
Cysteine | 2 | 2021 | 892 | 0.070 |
Why?
|
Chaperonin 60 | 1 | 2007 | 97 | 0.070 |
Why?
|
Genetic Engineering | 2 | 2008 | 933 | 0.070 |
Why?
|
Mycolic Acids | 1 | 2006 | 54 | 0.070 |
Why?
|
Heat Stress Disorders | 1 | 2007 | 80 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2008 | 1058 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2008 | 412 | 0.070 |
Why?
|
DNA, Single-Stranded | 1 | 2008 | 356 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 934 | 0.070 |
Why?
|
Bodily Secretions | 1 | 2005 | 27 | 0.060 |
Why?
|
Anticodon | 2 | 2016 | 26 | 0.060 |
Why?
|
Leukocyte Count | 7 | 1994 | 1596 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1743 | 0.060 |
Why?
|
Child | 26 | 2022 | 80162 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2007 | 398 | 0.060 |
Why?
|
Anaerobiosis | 1 | 2004 | 138 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 1998 | 3889 | 0.060 |
Why?
|
Antigens, Bacterial | 2 | 1987 | 1155 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5665 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 1999 | 4174 | 0.060 |
Why?
|
Protein Kinases | 1 | 2011 | 1607 | 0.060 |
Why?
|
Blotting, Northern | 2 | 2016 | 1545 | 0.060 |
Why?
|
Drug Resistance, Microbial | 2 | 1999 | 825 | 0.060 |
Why?
|
Tuberculin Test | 1 | 2004 | 206 | 0.060 |
Why?
|
Microbial Sensitivity Tests | 4 | 2012 | 1937 | 0.060 |
Why?
|
Humans | 44 | 2022 | 761423 | 0.050 |
Why?
|
Nitriles | 1 | 2008 | 971 | 0.050 |
Why?
|
Recombinant Proteins | 4 | 2012 | 6532 | 0.050 |
Why?
|
Intracranial Aneurysm | 1 | 1992 | 1285 | 0.050 |
Why?
|
Biological Products | 1 | 2012 | 912 | 0.050 |
Why?
|
HIV Antigens | 3 | 1993 | 325 | 0.050 |
Why?
|
Open Reading Frames | 3 | 2021 | 815 | 0.050 |
Why?
|
RNA, Transfer, Cys | 1 | 2021 | 3 | 0.050 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2005 | 621 | 0.050 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2001 | 52 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 1998 | 7389 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2448 | 0.050 |
Why?
|
Sulfur | 1 | 2021 | 162 | 0.050 |
Why?
|
Bulgaria | 1 | 2020 | 17 | 0.040 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2000 | 142 | 0.040 |
Why?
|
Thioredoxins | 1 | 2001 | 202 | 0.040 |
Why?
|
Drug Resistance, Viral | 1 | 2005 | 861 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9418 | 0.040 |
Why?
|
Submandibular Gland Diseases | 1 | 1999 | 22 | 0.040 |
Why?
|
Enzymes | 1 | 2021 | 258 | 0.040 |
Why?
|
Submandibular Gland | 1 | 1999 | 87 | 0.040 |
Why?
|
Parotid Diseases | 1 | 1999 | 49 | 0.040 |
Why?
|
Los Angeles | 1 | 2000 | 243 | 0.040 |
Why?
|
Thalassemia | 1 | 1980 | 268 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4467 | 0.040 |
Why?
|
Globins | 1 | 1980 | 403 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 1999 | 20556 | 0.040 |
Why?
|
Universities | 1 | 2004 | 993 | 0.040 |
Why?
|
Opportunistic Infections | 2 | 1992 | 376 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2000 | 785 | 0.040 |
Why?
|
DNA, Ribosomal | 1 | 2000 | 299 | 0.040 |
Why?
|
Mice | 5 | 2014 | 81509 | 0.040 |
Why?
|
Mutation | 4 | 2006 | 30045 | 0.040 |
Why?
|
Drug Evaluation | 4 | 1992 | 642 | 0.040 |
Why?
|
Water Supply | 1 | 2000 | 204 | 0.040 |
Why?
|
Florida | 1 | 2000 | 431 | 0.040 |
Why?
|
Parotid Gland | 1 | 1999 | 175 | 0.040 |
Why?
|
Risk-Taking | 1 | 2004 | 1037 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 1994 | 4370 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2012 | 7409 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3779 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3517 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2020 | 26212 | 0.040 |
Why?
|
Lymph Nodes | 2 | 1999 | 3466 | 0.040 |
Why?
|
Carbohydrate Conformation | 1 | 2017 | 206 | 0.040 |
Why?
|
Mycobacterium avium | 1 | 1997 | 29 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 771 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2003 | 2230 | 0.040 |
Why?
|
Female | 26 | 2005 | 392581 | 0.040 |
Why?
|
Transcription Factors | 1 | 1997 | 12125 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2001 | 1038 | 0.030 |
Why?
|
Temperature | 1 | 2003 | 2228 | 0.030 |
Why?
|
Acclimatization | 1 | 1997 | 113 | 0.030 |
Why?
|
Antiviral Agents | 4 | 1993 | 3057 | 0.030 |
Why?
|
Latent Tuberculosis | 1 | 2019 | 224 | 0.030 |
Why?
|
Proteomics | 1 | 2010 | 3845 | 0.030 |
Why?
|
Neck | 1 | 2001 | 734 | 0.030 |
Why?
|
Genes | 1 | 1980 | 1844 | 0.030 |
Why?
|
Animals | 7 | 2014 | 168441 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36423 | 0.030 |
Why?
|
Male | 23 | 2012 | 360736 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 3810 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9995 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1371 | 0.030 |
Why?
|
Plasmids | 2 | 1999 | 2269 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2025 | 0.030 |
Why?
|
Lipids | 1 | 2006 | 3340 | 0.030 |
Why?
|
DNA Transposable Elements | 1 | 1999 | 755 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18247 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10762 | 0.030 |
Why?
|
Orotidine-5'-Phosphate Decarboxylase | 1 | 1993 | 8 | 0.030 |
Why?
|
Molecular Biology | 1 | 1998 | 578 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 3612 | 0.030 |
Why?
|
Threonine | 1 | 2014 | 271 | 0.030 |
Why?
|
Macrophages | 1 | 2008 | 5768 | 0.030 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2005 | 2152 | 0.030 |
Why?
|
India | 1 | 2020 | 2349 | 0.030 |
Why?
|
Administration, Oral | 4 | 1994 | 4016 | 0.030 |
Why?
|
Species Specificity | 1 | 1997 | 2416 | 0.030 |
Why?
|
DNA Primers | 1 | 1997 | 2820 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1458 | 0.030 |
Why?
|
Raccoons | 1 | 2012 | 7 | 0.030 |
Why?
|
Phosphonoacetic Acid | 1 | 1992 | 54 | 0.030 |
Why?
|
Ascaridida Infections | 1 | 2012 | 7 | 0.030 |
Why?
|
Consensus Sequence | 1 | 2012 | 365 | 0.030 |
Why?
|
Retinitis | 1 | 1992 | 36 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 902 | 0.020 |
Why?
|
Albendazole | 1 | 2012 | 50 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4575 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2013 | 12796 | 0.020 |
Why?
|
Blotting, Western | 1 | 1999 | 5036 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2012 | 261 | 0.020 |
Why?
|
Colorimetry | 1 | 2012 | 148 | 0.020 |
Why?
|
Ganciclovir | 1 | 1992 | 252 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 398 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 283 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2014 | 729 | 0.020 |
Why?
|
Infusions, Intravenous | 2 | 1992 | 2218 | 0.020 |
Why?
|
Virus Cultivation | 1 | 1990 | 88 | 0.020 |
Why?
|
Kanamycin Kinase | 1 | 1990 | 34 | 0.020 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1991 | 242 | 0.020 |
Why?
|
Catheterization, Central Venous | 2 | 1992 | 527 | 0.020 |
Why?
|
Genomic Library | 1 | 1990 | 189 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1992 | 629 | 0.020 |
Why?
|
Bacteriophage lambda | 2 | 1999 | 142 | 0.020 |
Why?
|
United States | 4 | 2020 | 72339 | 0.020 |
Why?
|
Data Collection | 1 | 1998 | 3322 | 0.020 |
Why?
|
Adolescent | 13 | 1994 | 88313 | 0.020 |
Why?
|
Fungi | 1 | 2012 | 338 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 1995 | 2569 | 0.020 |
Why?
|
Rhodococcus | 1 | 2008 | 13 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1990 | 303 | 0.020 |
Why?
|
Pancreatitis | 2 | 1993 | 1096 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2022 | 7825 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2012 | 64651 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7856 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1993 | 914 | 0.020 |
Why?
|
Mass Screening | 1 | 2004 | 5428 | 0.020 |
Why?
|
Antigens, Viral | 1 | 1992 | 988 | 0.020 |
Why?
|
Cross Reactions | 2 | 1987 | 818 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7584 | 0.020 |
Why?
|
Risk Assessment | 2 | 2012 | 23990 | 0.020 |
Why?
|
Pseudomonas Infections | 1 | 1992 | 622 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3061 | 0.020 |
Why?
|
Ecosystem | 1 | 2012 | 490 | 0.020 |
Why?
|
Leiomyoma | 1 | 1992 | 636 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15717 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2008 | 275 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2498 | 0.020 |
Why?
|
Boston | 1 | 2000 | 9330 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 1992 | 1281 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
Bacterial Infections | 2 | 1992 | 1393 | 0.020 |
Why?
|
RNA, Viral | 1 | 1995 | 2846 | 0.020 |
Why?
|
DNA, Viral | 1 | 1993 | 2201 | 0.020 |
Why?
|
RNA Stability | 1 | 2008 | 329 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1990 | 796 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1994 | 4852 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 1067 | 0.020 |
Why?
|
Adult | 5 | 2020 | 221148 | 0.020 |
Why?
|
Retinal Diseases | 1 | 1992 | 704 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5439 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 831 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3580 | 0.020 |
Why?
|
Time Factors | 3 | 1997 | 39975 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12970 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2008 | 755 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 29862 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1876 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 8469 | 0.010 |
Why?
|
Bacteria | 1 | 2012 | 2199 | 0.010 |
Why?
|
Rabbits | 1 | 1987 | 4779 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1992 | 2538 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1993 | 5115 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1980 | 551 | 0.010 |
Why?
|
Hemoglobins, Abnormal | 1 | 1980 | 119 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1980 | 455 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 1987 | 10194 | 0.010 |
Why?
|
Rhodobacter capsulatus | 1 | 1999 | 11 | 0.010 |
Why?
|
Cyanobacteria | 1 | 1999 | 52 | 0.010 |
Why?
|
Conjugation, Genetic | 1 | 1999 | 116 | 0.010 |
Why?
|
Transposases | 1 | 1999 | 104 | 0.010 |
Why?
|
Streptomyces | 1 | 1999 | 91 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1980 | 1306 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2012 | 39117 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2008 | 2985 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1994 | 10766 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1980 | 2561 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1992 | 4320 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1999 | 656 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1980 | 1387 | 0.010 |
Why?
|
Epitopes | 2 | 1993 | 2507 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 852 | 0.010 |
Why?
|
Amylases | 1 | 1993 | 170 | 0.010 |
Why?
|
Xanthomonas | 1 | 1992 | 17 | 0.010 |
Why?
|
Foscarnet | 1 | 1992 | 35 | 0.010 |
Why?
|
Electrooculography | 1 | 1992 | 113 | 0.010 |
Why?
|
Absorption | 1 | 1992 | 243 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1999 | 80582 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1992 | 311 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1993 | 416 | 0.010 |
Why?
|
Pigment Epithelium of Eye | 1 | 1992 | 209 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1993 | 728 | 0.010 |
Why?
|
Age Factors | 3 | 1992 | 18400 | 0.010 |
Why?
|
Lipase | 1 | 1993 | 325 | 0.010 |
Why?
|
Half-Life | 1 | 1992 | 652 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 1991 | 161 | 0.010 |
Why?
|
Gene Products, gag | 1 | 1991 | 312 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1993 | 603 | 0.010 |
Why?
|
Fundus Oculi | 1 | 1992 | 556 | 0.010 |
Why?
|
Biological Availability | 1 | 1991 | 390 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22163 | 0.010 |
Why?
|
Platelet Count | 1 | 1992 | 782 | 0.010 |
Why?
|
Electroretinography | 1 | 1992 | 525 | 0.010 |
Why?
|
Drug Interactions | 1 | 1994 | 1414 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1992 | 793 | 0.000 |
Why?
|
Genome, Bacterial | 1 | 1993 | 783 | 0.000 |
Why?
|
Drug Monitoring | 1 | 1994 | 962 | 0.000 |
Why?
|
Tuberculin | 1 | 1987 | 64 | 0.000 |
Why?
|
Genetic Markers | 1 | 1993 | 2613 | 0.000 |
Why?
|
H-2 Antigens | 1 | 1987 | 358 | 0.000 |
Why?
|
Atrophy | 1 | 1992 | 1633 | 0.000 |
Why?
|
Hypersensitivity, Delayed | 1 | 1987 | 490 | 0.000 |
Why?
|
Lymphocyte Activation | 2 | 1987 | 5490 | 0.000 |
Why?
|
Brain | 1 | 1992 | 27107 | 0.000 |
Why?
|
Intelligence | 1 | 1991 | 924 | 0.000 |
Why?
|
Growth Substances | 1 | 1987 | 768 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1987 | 899 | 0.000 |
Why?
|
Immunization, Passive | 1 | 1987 | 616 | 0.000 |
Why?
|
Vaccines, Synthetic | 1 | 1987 | 619 | 0.000 |
Why?
|
Lymphokines | 1 | 1987 | 927 | 0.000 |
Why?
|
Clone Cells | 1 | 1987 | 1659 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1993 | 2300 | 0.000 |
Why?
|
Interleukin-4 | 1 | 1987 | 1150 | 0.000 |
Why?
|
Antigens, Surface | 1 | 1987 | 1609 | 0.000 |
Why?
|
Prognosis | 2 | 1993 | 29620 | 0.000 |
Why?
|
Brain Diseases | 1 | 1991 | 1545 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1993 | 4549 | 0.000 |
Why?
|
Retina | 1 | 1992 | 2658 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1987 | 1891 | 0.000 |
Why?
|
Antigens, CD | 1 | 1990 | 4001 | 0.000 |
Why?
|
Neutrophils | 1 | 1992 | 3766 | 0.000 |
Why?
|
Cohort Studies | 2 | 1992 | 41446 | 0.000 |
Why?
|
Pilot Projects | 1 | 1992 | 8633 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1987 | 3159 | 0.000 |
Why?
|
Sex Factors | 1 | 1992 | 10548 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1990 | 7045 | 0.000 |
Why?
|
Disease Progression | 1 | 1994 | 13502 | 0.000 |
Why?
|
Genetic Variation | 1 | 1993 | 6581 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 1993 | 15262 | 0.000 |
Why?
|
Liver | 1 | 1991 | 7532 | 0.000 |
Why?
|
Incidence | 1 | 1993 | 21341 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1992 | 22168 | 0.000 |
Why?
|
Prospective Studies | 1 | 1992 | 54415 | 0.000 |
Why?
|
Risk Factors | 1 | 1992 | 74167 | 0.000 |
Why?
|